Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
Anna Glajcar, Joanna Szpor, Diana Hodorowicz‐Zaniewska, et al.
Virchows Archiv (2019) Vol. 475, Iss. 1, pp. 13-23
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

A single-cell and spatially resolved atlas of human breast cancers
Sunny Z. Wu, Ghamdan Al‐Eryani, Daniel Roden, et al.
Nature Genetics (2021) Vol. 53, Iss. 9, pp. 1334-1347
Open Access | Times Cited: 968
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
Molly A. Nelson, Worapol Ngamcherdtrakul, Shiuh‐Wen Luoh, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 2, pp. 519-536
Open Access | Times Cited: 88
Understanding Immune Responses to Viruses—Do Underlying Th1/Th2 Cell Biases Predict Outcome?
Faith Howard, Amy Kwan, Natalie Winder, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1493-1493
Open Access | Times Cited: 38
Early-Stage Luminal B-Like Breast Cancer Exhibits a More Immunosuppressive Tumor Microenvironment than Luminal A-Like Breast Cancer
Tânia Moura, Olga Caramelo, Isabel Silva, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 78-78
Open Access | Times Cited: 1
High baseline tumor burden‐associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2‐STAT3‐PD‐L1 pathway
Zhaowei Wen, Huiying Sun, Zhihua Zhang, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 562-581
Open Access | Times Cited: 17
The Tumor Immune Microenvironment in Breast Cancer Progression
Marit Otterlei Fjørtoft, Kanutte Huse, Inga H. Rye
Acta Oncologica (2024) Vol. 63, pp. 359-367
Open Access | Times Cited: 5
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma
Wanzun Lin, Xianxin Qiu, Pian Sun, et al.
Molecular Therapy — Oncolytics (2021) Vol. 21, pp. 288-302
Open Access | Times Cited: 31
Clinical trial data and emerging strategies: HER2-positive breast cancer
Sònia Pernas, Sara M. Tolaney
Breast Cancer Research and Treatment (2022) Vol. 193, Iss. 2, pp. 281-291
Closed Access | Times Cited: 20
Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology
Bharati Mehani, Saleembhasha Asanigari, Hye‐Jung Chung, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 19
The current advances of lncRNAs in breast cancer immunobiology research
Marco Antonio Fonseca-Montaño, Karla Itzel Vázquez-Santillán, Alfredo Hidalgo‐Miranda
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Tumor-Infiltrating Lymphocytes and Neutrophils and Their Location in Canine Mammary Neoplasms with a Solid Arrangement: A Prognostic Factor?
Mayra Cunha Flecher, Marina Possa dos Reys, Débora Balabram, et al.
Animals (2025) Vol. 15, Iss. 2, pp. 287-287
Open Access
Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
Bei Li, Rongxin Geng, Qi Wu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 32
Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity
Tatiana S. Gerashchenko, A. A. Frolova, М. Р. Патышева, et al.
Advanced Biology (2024) Vol. 8, Iss. 7
Closed Access | Times Cited: 3
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
Tânia Moura, Paula Laranjeira, Olga Caramelo, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 143-143
Open Access
Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8+ T Cells in Breast Cancer
Philip B. Emmerich, Tonela Qyli, Katherine A. Johnson, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1435-1435
Open Access
Expression pattern, regulation, and clinical significance of TOX in breast cancer
Mohit Arora, Sarita Kumari, Jay Singh, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 2, pp. 349-363
Open Access | Times Cited: 21
Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancer
Mobina Jalalvand, Farzaneh Darbeheshti, Nima Rezaei
Immunotherapy (2021) Vol. 13, Iss. 7, pp. 587-603
Closed Access | Times Cited: 20
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy
Andrea Nicolini, Paola Ferrari, Roberto Silvestri, et al.
Journal of the National Cancer Center (2024) Vol. 4, Iss. 1, pp. 14-24
Open Access | Times Cited: 2
The effect of exercise and disease status on mobilization of anti-tumorigenic and pro-tumorigenic immune cells in women with breast cancer
Tiia Koivula, Salla Lempiäinen, Joona Neuvonen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes
Reiko Fukui, Yukie Fujimoto, Takahiro Watanabe, et al.
Anticancer Research (2020) Vol. 40, Iss. 4, pp. 2141-2150
Open Access | Times Cited: 16
Clinicopathologic Characteristics of Breast Cancer According to the Infiltrating Immune Cell Subtypes
Hye Min Kim, Ja Seung Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4438-4438
Open Access | Times Cited: 14
Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies
Jing Zhao, Jane Meisel, Yi Guo, et al.
Breast Cancer Research and Treatment (2020) Vol. 183, Iss. 3, pp. 599-606
Closed Access | Times Cited: 14
Protein-based immune profiles of basal-like vs. luminal breast cancers
Andrea Walens, Linnea T. Olsson, Xiaohua Gao, et al.
Laboratory Investigation (2021) Vol. 101, Iss. 6, pp. 785-793
Open Access | Times Cited: 12
Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs
Sim-In Lee, Chang‐Gi Jeong, Sameer ul Salam Mattoo, et al.
Vaccine (2021) Vol. 39, Iss. 45, pp. 6691-6699
Closed Access | Times Cited: 10
Breast cancers co-opt normal mechanisms of tolerance to promote immune evasion and metastasis
Lyndsey S. Crump, Kelsey Kines, Jennifer K. Richer, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 5, pp. C1475-C1495
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top